sprite-preloader
Anzeige
Mehr »
Sonntag, 15.07.2018 Börsentäglich über 12.000 News von 586 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrGenentech seeks FDA approval for Venclexta for AML
FrDermavant to buy rights to tapinarof from GSK for £250m
FrGenmab, Immatics to develop next-generation bispecific cancer immunotherapies
DoFDA grants priority review to Merck's sBLA for Keytruda to treat advanced hepatocellular carcinoma
DoAbbVie's blood cancer drug Ibrutinib fails in phase 3 DLBCL trial
DoOtsuka Pharmaceutical to buy biotechnology firm Visterra for $430m
MiBioNTech, Genevant to co-develop mRNA drugs for rare diseases
MiUS FTC approves Takeda's $62bn acquisition of Shire
MiCelgene's anti-PD-L1 immunotherapy plus Abraxane improves PFS in breast cancer study
MiBioCryst terminates merger deal with Idera Pharmaceuticals
MiEMA recalls certain heart drugs containing valsartan over safety fears
MiBioCryst Pharmaceuticals terminates merger deal with Idera Pharmaceuticals
DiTeneobio, Janssen to develop multispecific antibodies for oncology
DiHikma secures right to distribute Perrigo's products in MENA markets
DiAmryt secures funding approval from NHS England for bad cholesterol treatment
DiAlliance Pharma secures UK approval for nausea drug Diclectin
MoHerantis Pharma initiates non-invasive CDNF development program
MoOrion begins phase 3 trial of ALS drug levosimendan
MoAxovant, Benitec sign licensing deal for AXO-AAV-OPMD program
06.07.Cellect, denovoMATRIX to combine stem cell production technologies
06.07.EC approves expanded indication for BMS' Sprycel
06.07.Zynerba halts development of THC prodrug ZYN001
06.07.EMA accepts Clovis' application for expanded indication of Rubraca to treat ovarian cancer
05.07.NSF Release New Pharma eLearning Session - Update on EU Legislation and Guidance
05.07.ASLAN Pharmaceuticals submits clinical trial authorisation application for first in man studies for ASLAN004